Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials.
about
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of ChinaVentilator-associated pneumonia in the ICUCoagulase-negative staphylococci.Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis.Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis.Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients.Nosocomial methicillin resistant Staphylococcus aureus pneumonia - epidemiology and trends based on data of a network of 586 German ICUs (2005-2009)Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infectionsThe efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infectionsNovel classes of antibiotics or more of the same?The Japanese guidelines for the management of sepsis.Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?Comparative-effectiveness of vancomycin and linezolid as part of guideline-recommended empiric therapy for healthcare-associated pneumonia.No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period.Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.Clinical update on linezolid in the treatment of Gram-positive bacterial infections.Polymicrobial Ventilator-Associated Pneumonia: Fighting In Vitro Candida albicans-Pseudomonas aeruginosa Biofilms with Antifungal-Antibacterial Combination Therapy.Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer centerAssessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumoniaSusceptibility profile of methicillin-resistant Staphylococcus aureus to linezolid in clinical isolates.Multiresistant bacteria and current therapy - the economical side of the story.Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis.Antimicrobial resistance in internal medicine wards.Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties.An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy.Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials.Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence?Treating paediatric community-acquired pneumonia in the era of antimicrobial resistance.Vancomycin-associated renal dysfunction: where are we now?Ventilator-associated pneumonia: present understanding and ongoing debates.Ventilator-Associated Pneumonia (VAP) with Multidrug-Resistant (MDR) Pathogens: Optimal Treatment?Assessment of linezolid prescriptions in three French hospitals.Linezolid for the treatment of hospital-acquired pneumonia in a Chinese tertiary hospitalCochrane in context: Linezolid versus vancomycin for skin and soft tissue infections.A novel treatment option for MRSA pneumonia: ceftaroline fosamil-yielding new hope in the fight against a persistent infection.Year in review 2011: Critical Care - infection.
P2860
Q26749179-30AA3A75-DB84-47F3-B30D-07C9D6377BB5Q26862843-44B8B61C-2624-4CEC-BDB9-73A345AC7C9BQ30401758-FE7E7DFD-13DC-4B73-A760-F74D86A9F0A5Q30608976-66F70A68-DC59-4343-A3B7-B6CD04178646Q33410942-6B116EB1-40EA-4BF4-9F05-FD732A3687BFQ33418451-48F93894-BA33-435C-9D0F-CEE60F9CB80CQ33439246-D2E31C2F-7560-4262-9D4B-038A67F9868BQ33773159-A206F958-63A8-4C50-967E-28ED6CE368A4Q33786154-2FF99B4B-9496-4000-8CBF-1ABBB099BD65Q34618696-A5BE2C06-262A-4B8E-B1C2-CF8A4EC13463Q34903245-2CCE89EA-F4F8-4CBC-9EBE-6B51A5F18F7BQ35107094-C08510C3-14F8-4130-91A5-0E3F6D8D62DAQ35736907-F666A718-2ADC-4A20-8D86-265FD4B428D3Q35780121-3CD7D006-C790-4B1C-975B-DAE8A30E4897Q35785093-FDE30537-682F-4F3D-8EC0-C6172625CE69Q36078359-805092D6-E19D-45BF-9C17-AE838D7F9CBAQ36083208-5432FBBF-DDBF-4E98-9908-DBAB372BD92AQ36257537-05A4373B-254F-4715-84F4-DD52F8EA37B6Q36281234-693EA1CD-B52D-49AF-B509-10ED5A283F08Q36349620-4E7D122A-D8E6-497C-BBBD-67AE4A994A39Q37544870-BAF9E9DF-1C49-4C04-95E1-D2884C363AFCQ37668638-E0C1144F-680D-42A8-BF38-A57BEE1DE302Q37821606-9E16552B-7FC2-4208-9A37-65D1151313C9Q37949553-2E1EA3A1-921A-4A1A-88B1-153BE1B6C45EQ38052855-8B389633-CCEF-4E2F-9BEB-5C5B095E9E70Q38066654-A9DAA54B-C3EE-4BC3-B037-76F662C34F16Q38068293-BBD6A43F-03DB-4920-80A2-CF12EF6809C0Q38070154-2E622F1B-6D65-4D06-A83C-FB0D9B6A4EDDQ38097374-3F0C2BD8-C70A-4761-B2D1-C9564ED793F1Q38110140-D2417BA7-66A7-4453-8EDF-5C3182E0BA1EQ38170557-9EC8A76C-DEAD-4F2F-AF17-550D7EDBC0DDQ38249103-EE48A3E0-610B-46B3-89F3-064A2BA75D2DQ38271775-F894C1DC-2483-473A-BFD8-EB560B6B6ECDQ38532531-C3B470BD-4CD1-499C-9ABD-487E374973A5Q40356411-5D626702-D1E1-4557-B31F-E3B7EFF46A9BQ40914358-ADF74B1F-D079-43E5-ABC4-B9831842EDABQ41657769-A36245C2-556E-4AFA-B637-5192A33DDC0DQ45733591-9D44DEB9-210F-4D4A-84EC-7C2C41333168Q46626184-940BEED9-6806-4F6C-BA12-5C634F814876
P2860
Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Linezolid vs glycopeptide anti ...... randomized controlled trials.
@ast
Linezolid vs glycopeptide anti ...... randomized controlled trials.
@en
Linezolid vs glycopeptide anti ...... randomized controlled trials.
@nl
type
label
Linezolid vs glycopeptide anti ...... randomized controlled trials.
@ast
Linezolid vs glycopeptide anti ...... randomized controlled trials.
@en
Linezolid vs glycopeptide anti ...... randomized controlled trials.
@nl
prefLabel
Linezolid vs glycopeptide anti ...... randomized controlled trials.
@ast
Linezolid vs glycopeptide anti ...... randomized controlled trials.
@en
Linezolid vs glycopeptide anti ...... randomized controlled trials.
@nl
P2860
P921
P356
P1433
P1476
Linezolid vs glycopeptide anti ...... randomized controlled trials.
@en
P2093
Max R O'Donnell
P2860
P304
P356
10.1378/CHEST.10-1556
P407
P577
2010-09-23T00:00:00Z